Basket | Login | Register

 
 
 
 

Norway

Reimbursement of anti-dementia drugs

The availability of medicines in general

The Norwegian system differentiates between important and less important medicines.

For less important medicines, the patient pays the full cost, even if they have been prescribed by a doctor. Nevertheless, under certain conditions, it is possible for patients to claim a refund of 90% of all costs exceeding NOK 1,600 (approx. € 200).

For drugs on the important medicines list, patients are required to pay 36% of the cost. This only applies to the cost of drugs up to a ceiling of NOK 500 (approx. € 63) for a three months period. Costs over that ceiling are fully covered by the reimbursement system and no costs are incurred by the patient. Similarly, pensioners in receipt of a minimum pension do not need to pay cost-sharing charges for important medicines. [1]

The availability of Alzheimer treatments

All four anti-dementia drugs are available to patients in Norway, but memantine is not on the list of important medicines and is thus not reimbursed. Nevertheless, the Norwegian Alzheimer’s association explains that it is possible for doctors to fill out a form for memantine indicating that the drug is important and needs to be taken over a long period of time. In such cases, memantine can be partially reimbursed with a part of the costs borne by the patient.

Norway does not limit the prescription of anti-dementia drugs to specialist doctors, since the rules only state that the physician must have an interest in and knowledge about dementia. A diagnosis of Alzheimer’s disease and an MMSE score over 12 are the only requirements for the reimbursement of acetylcholinesterase inhibitors. Also, the Norwegian system reimburses medicines for people living alone or in nursing homes.

 

Donepezil

Rivastigmine

Galantamine

Memantine

Reimbursement

Yes

Yes

Yes

No

Initial treatment decision

No restrictions

No restrictions

No restrictions

N/A

Continuing treatment decision

No restrictions

No restrictions

No restrictions

N/A

Required examinations

MMSE

MMSE

MMSE

N/A

MMSE limits

> 12

> 12

> 12

N/A

People living alone

No restrictions

No restrictions

No restrictions

N/A

People in nursing homes

No restrictions

No restrictions

No restrictions

N/A

[1] European Commission (2006): MISSOC – Mutual information system on social protection : Social protection in the Member States of the European Union, of the European Economic Area and in Switzerland : Comparative tables

 

 
 

Last Updated: mercredi 15 juillet 2009

 

 
 

Options

  • Send this page to a friend